OSU News Research Archive
Search an archive of past research stories.
Coverage of OSU Research
Reports on national news coverage of university research.
Reporting on Cancer
A reporter's guide to the disease.
Science Communications Staff
Who we are and what we do.
 
 

(Last updated 11/5/03)

Editor's note: From Nov. 8 through Nov. 12, Lin will be at the Society for Neuroscience meeting and can be reached at the Days Inn Canal Street at (504) 586-0110.

From Nov. 8 through Nov. 11, Wagner can be reached at (614) 596-5053 or at the Sheraton New Orleans at (504) 525-2500.

[Embargoed for release until 11:00 AM ET Monday, Nov. 10, 2003, to coincide with a presentation at the Society for Neuroscience meeting in New Orleans.]

RESEARCHERS FIND ROLE RNA PLAYS IN PROGRESS OF ALZHEIMER'S DISEASE

NEW ORLEANS – Researchers at Ohio State University have found new clues to how free radicals can contribute to the development of Alzheimer's disease.

C. Glenn Lin

The study found that oxidation – a type of damage to cells caused by free radicals – can damage certain kinds of messenger RNA in the brain. That damage may be related to Alzheimer's.

Messenger RNA (or mRNA) is important because it turns DNA's genetic code into the proteins needed for healthy brain function. But in an Alzheimer's brain, up to half of the mRNA are damaged by oxidation; these oxidized mRNAs may process proteins abnormally, which may contribute to neuronal death.

“We know that free radicals can damage DNA, but nobody had looked at the effect of free radicals on RNA," said C. Glenn Lin, the study's lead author and an assistant professor of neuroscience at Ohio State. "When we looked for mRNA in the Alzheimer's brain, we found significant amounts of oxidized mRNA in the frontal cortex, which is one of the main areas affected by the disease."


"We think that mRNA oxidation and subsequent protein accumulation may strongly interfere with the brain's normal cellular processes, which may contribute to the onset and progression of Alzheimer's."


The researchers looked at the brains of deceased Alzheimer's patients and found that only certain kinds of mRNA are susceptible to oxidative damage. There are many, some of which researchers have yet to discover, Lin said.

This is the first study to describe the specific types, or species, of mRNA oxidized in Alzheimer's disease; until this point, researchers knew that the oxidation of mRNA played a role in Alzheimer's disease, but they didn't know which species were at fault.

Lin and Ohio State colleagues Xiu Shan and Hirofumi Tashiro, both with the department of neuroscience, reported their findings on November 10 in New Orleans at the annual Society for Neuroscience conference.

The researchers used tissue taken from the brains of 11 recently deceased Alzheimer's patients (aged 65 to 86); seven age-matched controls; and two young control subjects (aged 22 and 49). Using a series of biochemical testing methods, they analyzed mRNA content from the hippocampus, frontal cortex and cerebellum of each person's brain. They were looking for mRNA transcripts – replicas of DNA genetic code – to see if certain transcripts were more susceptible to oxidation.

The researchers also wanted to see if they would find the same level of mRNA oxidation in the brains of the age-matched and young controls to determine whether or not this level of mRNA oxidation was truly unique to Alzheimer's disease.

Alzheimer's disease first attacks the hippocampus, virtually destroying its ability to help regulate memory. Damage to the frontal cortex – an area important for cognition – follows. The cerebellum is usually unaffected in Alzheimer's, Lin said.

The researchers found high levels of oxidative damage in the frontal cortex of only the Alzheimer's patients' brains. They also found that only certain mRNA species were oxidized.

"We were somewhat surprised to find that free radical damage wasn't a random hit in the brain," Lin said. "But many of the oxidized mRNA species were related to genes already known to be associated with Alzheimer's disease."

This oxidation appears to start early in the disease process, Lin said, and the disease progressively worsens as proteins continue to accumulate.

"Protein aggregation is one of the hallmark features of Alzheimer's disease," Lin said. "We think that mRNA oxidation and subsequent protein accumulation may strongly interfere with the brain's normal cellular processes, which may contribute to the onset and progression of Alzheimer's."

Lin said he hopes that some day researchers will be able to pinpoint the exact kinds of mRNA transcripts that cause protein aggregation.
"That might help us figure out what kind of proteins in the cell go haywire at an early stage of Alzheimer's," he said. "Then, if we can somehow block that process, perhaps we could reduce the progression of the disease."

The research was supported by grants from the National Institutes of Health and the Alzheimer's Association.


#

Contact: C. Glenn Lin; (614) 688-5433; Lin.492@osu.edu

Written by Holly Wagner, (614) 292-8310; Wagner.235@osu.edu